Warren Fingrut is a Hematology physician affiliated with National Marrow Donor Program. OpenAlex indexes 133 publications with 747 citations (h-index 14); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1515 Holcombe Blvd
Houston, TX 770304000
Telephone
713-792-6161Provider last certified this registry record 19 Oct 2023.
Clinical trials
- Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
Sponsor: M.D. Anderson Cancer Center
- Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health
Sponsor: M.D. Anderson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- National Marrow Donor ProgramProgram year20252 payments
- Astellas Pharma US IncProgram year20255 payments
- Incyte CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mesenchymal stem cells in hematology: Therapeutic initiatives and future directions
Best Practice & Research Clinical Haematology
2025 - Building health advocacy campaigns to engage sexual and gender minority populations with health care
The Lancet Haematology
2025 - Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide (PTCy)-Based Graft-Versus-Host Disease Prophylaxis
Biology of Blood and Marrow Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Devine, MD
National Marrow Donor Program
Dennis Confer, MD
National Marrow Donor Program
Heather Stefanski, MD, PhD
National Marrow Donor Program
Alfred Grovas, MD
National Marrow Donor Program
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”